Neuropathic Pain

A recent study looked at the effect from injections of recombinant human growth hormone (HGH) and testosterone to the painful and dysfunctional areas in patients with chronic lower back pain.

Research has shown that massage therapy is more effective than no therapy at all. A recent study sought to determine if there is a link between massage duration and effective analgesia for neck pain.

A recent study looked into the neural functions affected by ibuprofen and found some connections that may soon lead to a much greater understanding of the greatest pain mitigator of them all: the brain.

Although some studies have hinted at a possible role for metformin in pain management, a recent investigation found no difference in pain scores among diabetic patients who used metformin and those who did not

Post-mastectomy neuropathic pain can be reduced in nearly one-third of women if the right assessments are completed.

Researchers have demonstrate the efficacy of an implantable organic electronic delivery device for the treatment of neuropathic pain in an animal model. The small organic electronic ion pump could be an effective option for patients suffering from severe nerve pain.

Virtual reality experiments determined that the threshold of pain is increased when the participants do not know the degree of rotation is manipulated.

The next step in reducing and preventing neuropathic pain has been identified, according to researchers from UC Davis.

For many years the dangers of opioid addiction have been well known. Taking the steps needed to reverse its impact has been slower in taking hold across the country.

Canada- and Switzerland-based researchers discovered that a specific gene, that is typically associated with a rare disease, plays an important role in how pain is processed in the body.

A case study published in the Journal of Medical Case Reports about one patient with syringomyelia demonstrated the common confusion about diagnosing this disease.

Interventional pain management-the field of helping patients with acute or chronic pain without doing major surgery--is a both a growing specialty and one that is under assault. As the annual meeting of the American Society of Interventional Pain Physicians got underway in Orlando, FL today, group leaders outlined the organization's political agenda.

Treating drug-resistant trigeminal neuralgia with stereotactic radiosurgery with linear accelerators is effective and safe, based on a literature review published in Pain Physician.

Electrical pulses targeting the dorsal column were effective in treating Parkinson's disease-like symptoms in mice.

Researchers say "scrambler therapy" can be used to treat pediatric complex regional pain syndrome.

Investigators believe they may have identified a potential "off switch" for pain, according to study results published in the journal Brain.

After a period of 6 months from post herpetic neuralgia onset, patients often report chronic pain, according to a study conducted in Rome, Italy.

Results from a study of herpes zoster incidence following periods of acute stress in a large cohort of patients suggest the conventional wisdom on this subject may be wrong.

Although methadone accounts for only 2% of opioid prescriptions, it caused nearly one in 3 prescription opioid overdose deaths in 2012, a 6-fold increase from 2009, according to the CDC.

Because there is no objective test for pain, and because each patient's experience of his or her painful condition is subjective and unique, physicians who treat these patients must process a variety of symptoms, signs, and cues to determine whether they can trust their patient's narrative.

Bodily pain and headache are highly prevalent in pituitary disease, making pain screening and therapy an important part of the work-up for these patients.

Treatment-resistant cases of trigeminal neuralgia may be treated with duloxetine, according to a new case study.

An Australian team of researchers injected 10 female neuropathic pain patients with stem cells, which were overall, well-tolerated, according to research published in the Journal of Pain Research.

Abuse-deterrent properties, identical efficacy for pain relief, reversal of opioid-induced constipation, and theoretical tolerance mitigation may give Targiniq ER an interesting advantage over other oral opioids.

Researchers in Saint Louis are examining the ways in which a drug already approved for multiple sclerosis could ease some of the pain associated with chemotherapy for cancer patients.